Blockade of cyclooxygenase-2 inhibits proliferation and induces apoptosis in human pancreatic cancer cells

Anticancer Research

Volumn 20, Issue 4, 2000, Pages 2625-2631

  Ding, Xian Zhong ^a   Tong, Wei Gang ^a   Adrian, Thomas E ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; COX; Cycloooxygenase; Pancreatic cancer

Indexed keywords

CYCLOOXYGENASE 2; INDOMETACIN; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; PROSTAGLANDIN SYNTHASE INHIBITOR;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; HUMAN; HUMAN CELL; NICK END LABELING; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL DIVISION; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; IN SITU NICK-END LABELING; INDOMETHACIN; ISOENZYMES; MEMBRANE PROTEINS; NITROBENZENES; PANCREATIC NEOPLASMS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RNA, MESSENGER; SULFONAMIDES; TUMOR CELLS, CULTURED;

EID: 0033859744     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Parker SL, Tong T, Bolden S, et al: Cancer Statistics. 1996. CA Cancer J Clin 46: 5-27, 1996.
2. Trede M, Schwall G, Saeger H: Survival after pancreaticoduodenectomy: 118 consecutive resections without an operative mortality. Ann Surg 211: 447-458, 1990.
3. Cameron JL, Pitt HA, Yeo CJ, et al: One hundred and forty-five consecutive pancreatico-duodenectomies without mortality. Ann Surg 217: 430-438, 1993.
4. Horward TJ: Pancreatic adenocarcinoma. Curr Prob Cancer 20: 286-293, 1996.
5. Fischer SM, Hagerman RA, Li-Stiles E, Lo HH, Maldve RE, Belury MA, Locniskar MF: Arachidonate has protumor-promoting action that is inhibited by linoleate in mouse skin carcinogenosis. J Nutr 126: 1900S-1104S, 1996.
6. Poston GJ, Gillespie J, Guillou PJ: Gut. Biology of pancreatic cancer. 32: 800-812, 1991.
7. Black AW, Cox AD, Tepper JE: Treatment of pancreatic cancer: current limitations, future possibilities. Oncology 10: 301-307, 1996.
8. Doll R, Peto R: Mortality in relation to smoking: 20 years observations on male British doctors. BMJ 2: 1525-1536, 1976.
9. Simonson, MS, Wolfe JA, Dunn MJ: Regulation of prostaglandin synthesis by differential expression of the gene encoding prostaglandin endoperoxide syntliase. In: Advances in Prostaglandin, Thromboxane and Leukotiene Research, Eds: Sammuelsson B, Ramwell P, Paoletti R. Raven Press, NY, 21-69, 1990.
10. Smith WL, DeWitt DL, Kraemer SA, Andrews MJ, Hla T, Maciag T, Shimokawa T: Structure-function relationships in sheep, mouse, and human prostaglandin endoperoxide G/H synthases. In: Advances in Prostaglandin, Thromboxane and Leukotiene Research. Eds: Samuelsson B, Ramwell P, Paoletti R. Raven Press, NY, 21-29, 1990.
11. Holtzman MJ, Zhang V, Hussain H, et al: prostaglandin H synthase and lipoxygenase gene families in the epitheliap cell barrier. Ann New York Acad Sci 744: 58-77, 1994.
12. Maldve R & SM Fischer: Multifactor regulation of prostaglandin H synthase-2 in murine keratinocytes. Mol Carcinogenesis 17; 207-216, 1996.
13. Reddy BS: Chemoprevention of colon cancer by dietary administration of naturally-occurring and related synthetic agents. Adv Exp Med Biol 400B: 931-936, 1997.
14. Shao J, Sheng H, Aramandla R, Pereira MA, Lubet RA, Hawk E, Grogan L, Kirsch IR, Washington MK, Beauchamp RD, DuBois RN: Coordinate regulation of cyclooxygenase-2 and TGF-betal in replication error-positive colon cancer and azoxymethane-induced rat colonic tumors. Carcinogenesis 20: 185-191, 1999.
15. Slattery ML, Potter JD, Duncan DM, Berry TD: Dietary fats and colon cancer: assessment of risk associated with specific fatty acids. Int J Cancer 73: 670-677, 1997.
16. Fukutake M, Nakatsugi S, Isoi T, Takahashi M, Ohta T, Mamiya S, Taniguchi Y, Sato H, Fukuda K, Sugimura T, Wakabayashi K: Suppressive effects of nimesulide, a selective inhibitor of cyclooxygenase-2, on azoxymethane-induced colon carcinogenesis in mice. Carcinogenesis 19: 1939-1942, 1998.
17. Kawamori T, Rao CV, Seibert K, Reddy BS: Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Res 58: 409-412, 1998.
18. Singh J, Hamid R, Reddy BS: Dietary fat and colon cancer: modulation of cyclooxygenase- 2 by types and amount of dietary fat during the postinitiation stage of colon carcinogenesis. Cancer Res 57: 3465-3470, 1997.
19. Thun MJ: NSAID use and decreased risk of gastrointestinal cancers. Gastroenterol Clin North Am 25: 333-348, 1996.
20. Shiff SJ, Rigas B: Nonsteroidal anti-inflammatory drugs and colorectal cancer: evolving concepts of their chemopreventive actions. Gastroenterology 113: 1882-1998, 1997.